Comparison of Efficacy Between ILM Forceps

Launched by UNIVERSITY OF BRITISH COLUMBIA · Jul 30, 2024

Keywords

ClinConnect Summary

This clinical trial is looking at the effectiveness of a specific tool called ILM forceps used during surgery for certain eye conditions, specifically macular holes and epiretinal membranes. The goal is to determine how well this tool helps improve vision after surgery. The study will involve patients who are 19 years and older, and who have symptoms related to these eye conditions that require surgery to remove a thin membrane on the retina. However, individuals with certain other eye problems, like diabetes-related eye issues or previous eye surgeries, won't be eligible to participate.

If you join this trial, you will be evaluated before the surgery, during the surgery, and then again one month after the surgery to see how your vision has changed. The researchers will measure your eyesight and use a special imaging test called optical coherence tomography (OCT) to observe changes in the retina. It’s important to know that the trial is not yet recruiting participants, so if you’re interested, you may need to wait for it to start.

Gender

ALL

Eligibility criteria

• Inclusion Criteria:
• • • 19y and older patients with symptomatic ERM (grade 2-3) or Macular hole (non flap-requiring) for elective ILM peeling surgery.
• Exclusion Criteria:
• • Co-morbid diabetic retinopathy of any grade.
• • Neovascular AMD.
• • Previous vitrectomy.
• • Previous retinal detachment treated with scleral buckle or pneumatic retinopexy.
• • Uncontrolled glaucoma or previous glaucoma surgery.
• • Combined phacovitrectomy.
• • Macula holes with severity requiring flap.